| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-07-4732 |
| P698 | PubMed publication ID | 18559615 |
| P2093 | author name string | Karin Jooss | |
| Shanthi Ganesh | |||
| Melinda Van Roey | |||
| Melissa Gonzalez-Edick | |||
| Douglas Gibbons | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncolytic virus | Q1560099 |
| Adenoviridae | Q193447 | ||
| P304 | page(s) | 3933-3941 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models | |
| P478 | volume | 14 |
| Q58609439 | A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer |
| Q39807606 | A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses. |
| Q49963933 | A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy |
| Q36951268 | Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth |
| Q39861470 | Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo |
| Q37287118 | Advances in oncolytic virus therapy for glioma |
| Q30596466 | Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix |
| Q48014782 | Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study |
| Q42259034 | Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10. |
| Q47547386 | Designing and building oncolytic viruses |
| Q38944271 | Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy. |
| Q42846593 | Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models |
| Q53272922 | From Benchtop to Bedside: A Review of Oncolytic Virotherapy. |
| Q92345899 | GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival |
| Q37158534 | Gene therapy: the end of the rainbow? |
| Q33713824 | Herpes simplex virus oncolytic therapy for pediatric malignancies |
| Q39362821 | Hyaluronan degrading silica nanoparticles for skin cancer therapy. |
| Q34025129 | Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth |
| Q33895533 | Impact of tumor microenvironment on oncolytic viral therapy |
| Q24628227 | Intelligent design: combination therapy with oncolytic viruses |
| Q39208944 | Intraductal delivery of adenoviruses targets pancreatic tumors in transgenic Ela-myc mice and orthotopic xenografts |
| Q57895597 | Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development |
| Q36751597 | Murine Tumor Models for Oncolytic Rhabdo-Virotherapy |
| Q37899230 | Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress |
| Q33906116 | Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles |
| Q39240683 | Oncolytic viral therapy for pancreatic cancer. |
| Q38025263 | Oncolytic virotherapy |
| Q38924562 | Oncolytic virotherapy for head and neck cancer: current research and future developments |
| Q36634430 | Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice |
| Q38033591 | Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets |
| Q38219844 | Oncolytic viruses for potential osteosarcoma therapy |
| Q38577450 | Oncolytic viruses: a new class of immunotherapy drugs |
| Q38025696 | Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy. |
| Q91776793 | Optimizing oncolytic virotherapy in cancer treatment |
| Q42934744 | Panorama from the oncolytic virotherapy summit |
| Q45868822 | Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer |
| Q101139011 | Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma |
| Q38125197 | Strategies to increase drug penetration in solid tumors |
| Q64244093 | Synergistic Effects of Bortezomib-OV Therapy and Anti-Invasive Strategies in Glioblastoma: A Mathematical Model |
| Q37459624 | The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy |
| Q37028023 | Trial watch: Oncolytic viruses for cancer therapy |
| Q48310617 | Viral vectors: promising new therapeutics in the battle against glioblastoma |
Search more.